Pharmacy
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Pharmacy
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Pharmacy
        Adverse Drug Reactions
        Antimicrobials
        Basic Science
        Cardiac/Hypertension
        Chemotherapy/Oncology
        Complementary Medicine
        Dosing
        Drug Approvals
        Drug Interactions
        Drug Resistance
        Drug Trials
        Drug/Product Alerts
        Economics of Medicine
        Major Studies
        Neuro/Psych pharmacology
        Other Drugs
        Over The Counter (OTC)
        Pain Management
        Patient Counseling
        Pharmacoeconomics
        Pharmacokinetics
        Pharmacy Management
        Popular Press
        Stomach/GI
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor

Messages


Articles: Drug Approvals



Latest () Month's Top Read  
Receive free subspecialty "5-minute updates" via email
Cell Therapeutics Applies for European Orphan Drug Designation for Pixantrone in Aggressive Non-Hodgkins Lymphoma
Cell Therapeutics, 09/30/09    Free full text
Sponsor
Two-Year Efficacy and Safety of AIR Inhaled Insulin in Patients with Type 1 Diabetes: An Open-Label Randomized Controlled Trial
Diabetes Technology & Therapeutics, 09/29/09
Allos Therapeutics' FOLOTYN(TM) First and Only FDA-Approved Therapy for Relapsed or Refractory Peripheral T-cell Lymphoma
Allos Therapeutics, 09/28/09    Free full text
Allos Therapeutics Announces FDA Advisory Committee Recommends Accelerated Approval of FOLOTYN(TM) for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
Allos Therapeutics, 09/28/09    Free full text
Novartis bronchodilator QAB149 recommended for approval in European Union to treat patients with chronic obstructive pulmonary disease
Novartis, 09/28/09    Free full text
Multaq Recommended for Approval in the European Union
Sanofi-aventis, 09/28/09    Free full text
FDA Advisory Committee Hears Presentations and Public Comment on EXALGO Extended-Release Tablets
Covidien, 09/28/09
Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration
Annals of Pharmacotherapy, 09/25/09
Anti-Cancer Agent Xeloda and Avastin Obtained Approval for Additional Indication of Colorectal Cancer
Chugai Pharmaceutical Co., 09/25/09    Free full text
Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
Cephalon, 09/25/09    Free full text
European Commission Grants Conditional Marketing Authorization to Cayston for the Treatment of Chronic Pulmonary Infections Due to Pseudomonas Aeruginosa in Patients with Cystic Fibrosis
Gilead, 09/24/09    Free full text
Analysis of Drug Authentication at the Point of Dispensing in Belgian and Greek Community Pharmacies
Annals of Pharmacotherapy, 09/23/09
Physio-Control Receives Market Approval from Health Canada for LIFEPAK 15 Monitor/Defibrillator
Medtronic, 09/23/09    Free full text
Abbott Receives FDA Approval for First Fully Automated Blood Screening Test for HIV-1/HIV-2
Abbott, 09/22/09
Antineoplastic Agent / Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Tarceva®Application for Approval of Additional Indication of Pancreatic Cancer
Chugai Pharmaceutical Co., 09/21/09    Free full text
Update on FDA Registration of Actemra, a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody for Rheumatoid Arthritis
Chugai Pharmaceutical Co., 09/21/09    Free full text
Pivotal studies of orphan drugs approved for neurological diseases
Annals of Neurology, 09/18/09
APP Pharmaceuticals Receives Approval for Deferoxamine Mesylate for Injection, USP
American Pharmaceutical Partners, 09/18/09    Free full text
Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09    Free full text
Bevacizumab: Monoclonal antibody approved for the treatment of metastatic renal cell carcinoma in combination with interferon alfa
Formulary, 09/17/09    Free full text

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist more...
165 Available Pages
First    Prev    4      5      6      7      8      9      10      11      12      13      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Pharmacy Articles Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.